The World Health Organization recently released a daily outbreak report that the new coronavirus and influenza virus, although both cause respiratory diseases, but the two have the following differences: First, the rate of transmission is different. New coronary pneumonia travels more slowly than influenza, but the median incubation period is longer.
Photo by Spirit Common Health
Second, patients spread the virus for different times. Influenza virus transmission occurs mainly within 3 to 5 days of the patient’s onset of symptoms, and may also spread before symptoms appear. By contrast, while some cases of new coronary pneumonia can spread the virus 24 to 48 hours before symptoms appear, this is not the main issue at the moment.
Third, the infectious power is different. According to the assessment of the basic number of infections, the infection of new coronary pneumonia is stronger than that of influenza, with one patient infecting about 2 to 2.5 people. However, the assessment of the infectious power of the two viruses is relevant to the specific environment and time.
Fourth, the proportion of severe illness is different. Data to date indicate that 80% of new coronavirus infections are mild or asymptomatic, 15% are severe and 5% are very serious. The proportion of severe and very serious infections is higher than that of influenza.
Fifth, there is a certain difference between the susceptible crowd. The main risk groups for influenza include children, pregnant women, the elderly, people with other chronic conditions and people with problems with the immune system. With regard to new coronary pneumonia, current studies have shown that older people and people with other diseases are at higher risk of serious infection.
Sixth, the mortality rate is different. Although it will take some time to determine the mortality rate for new coronary pneumonia, current data show that the mortality rate for new coronary pneumonia is about 3% to 4%, while seasonal influenza mortality rates are usually well below 0.1%.
Seventh, medical interventions are different. Antiviral drugs and vaccines are available for influenza, but there is currently no new licensed vaccine or treatment for coronary pneumonia. THE WHO SAYS MANY THERAPEUTIC DRUGS ARE CURRENTLY BEING TESTED IN CHINA AND MORE THAN 20 VACCINES ARE BEING DEVELOPED.